These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26540380)

  • 21. Genome editing technologies and their potential to treat neurologic disease.
    Madigan NN; Staff NP; Windebank AJ; Benarroch EE
    Neurology; 2017 Oct; 89(16):1739-1748. PubMed ID: 28931646
    [No Abstract]   [Full Text] [Related]  

  • 22. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
    Mojica FJM; Montoliu L
    Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 24. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating Immunodeficiency through HSC Gene Therapy.
    Booth C; Gaspar HB; Thrasher AJ
    Trends Mol Med; 2016 Apr; 22(4):317-327. PubMed ID: 26993219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Editing: A New Tool for Viral Disease.
    Kennedy EM; Cullen BR
    Annu Rev Med; 2017 Jan; 68():401-411. PubMed ID: 27576009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo gene therapy potentials of CRISPR-Cas9.
    Xue HY; Zhang X; Wang Y; Xiaojie L; Dai WJ; Xu Y
    Gene Ther; 2016 Jul; 23(7):557-9. PubMed ID: 27029608
    [No Abstract]   [Full Text] [Related]  

  • 29. Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection.
    Deng Q; Chen Z; Shi L; Lin H
    Rev Med Virol; 2018 Sep; 28(5):e1998. PubMed ID: 30024073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 31. 'Base editors' open new way to fix mutations.
    Cohen J
    Science; 2017 Oct; 358(6362):432-433. PubMed ID: 29074746
    [No Abstract]   [Full Text] [Related]  

  • 32. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling the potential of CRISPR-Cas9 for gene therapy.
    Barrangou R; May AP
    Expert Opin Biol Ther; 2015 Mar; 15(3):311-4. PubMed ID: 25535790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.
    Uppada V; Gokara M; Rasineni GK
    Gene; 2018 May; 656():22-29. PubMed ID: 29496558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
    Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
    J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multifunctional AAV-CRISPR-Cas9 and its host response.
    Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
    Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Gene-Editing Tool Slowly Advances Into the Clinic.
    Jenks S
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
    [No Abstract]   [Full Text] [Related]  

  • 40. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
    Han Y; Li QW
    Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.